- recruiting
Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
This study looks at how well two medicines, encorafenib and binimetinib, work together for people with a specific type of advanced melanoma. It also checks on side effects and how it affects quality of life in everyday healthcare, outside of a strict clinical trial setting.
Austria · Germany · Switzerland - active not recruitingPHASE2
SCIB1 and iSCIB1+ in Melanoma Patients Receiving Nivolumab With Ipilimumab or SCIB1 With Pembrolizumab (The SCOPE Study)
This study looks at new cancer vaccines, SCIB1 and iSCIB1+, for advanced skin cancer (melanoma). They are being tested with standard treatments (nivolumab/ipilimumab or pembrolizumab) to see if they are safe and can help these treatments work better or for longer.
United Kingdom